Trial Profile
Phase II trial of irinotecan base regimen of bevacizumab for metastatic colorectal cancer progressed on oxaliplatin base regimen of bevacizumab
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Jan 2013
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Irinotecan (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Gimeracil/oteracil/tegafur
- Indications Colorectal cancer
- Focus Therapeutic Use
- 23 Jan 2013 New trial record